Immunization With Autologous Dendritic Cells is Associated With Extended Survival in Glioblastoma Patients
Time: 11:45 am
day: Conference Day One
Details:
- Results of Phase III trial
- Novel trial design using external controls
- Mechanism of action of dendritic cell-based immunotherapy
- Manufacturing of autologous cell-based products
